loading

Bridgebio Oncology Therapeutics Inc Stock (BBOT) Forecast

The Bridgebio Oncology Therapeutics Inc (BBOT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.00, representing a -100.00% decrease from the current price of $10.39. The highest analyst price target is $0.00, and the lowest is $0.00.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BBOT Price Target
Average 0.00 (-100.00% Downside)
loading

Is Bridgebio Oncology Therapeutics Inc (BBOT) A Buy Now?

Oscillators
Name Value Action
RSI(14) 52.07 Neutral
STOCH(9,6) 46.38 Neutral
STOCHRSI(14) 0.00 Neutral
MACD(12,26) 0.00 Neutral
ADX(14) 0.00 Neutral
William %R -56.71 Neutral
CCI(14) 38.67 Neutral
Buy: 0 Sell: 0 Neutral: 7
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
10.02
Buy
10.13
Buy
MA20
9.9648
Buy
9.9872
Buy
MA50
4.1857
Buy
0.00
Buy
MA100
2.0929
Buy
0.00
Buy
MA200
1.0464
Buy
0.00
Buy
Buy: 10 Sell: 0 Neutral: 0
Summary: Buy
According to our latest analysis, BBOT could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 0 signaling Sell signals and 7 Neutral signals. This might be a good time to open fresh positions on BBOT, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 52.07 indicates that BBOT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 46.38 indicates that BBOT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 0 indicates that BBOT is oversold. This suggests that BBOT price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 0 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 38.67 indicates that BBOT is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Bridgebio Oncology Therapeutics Inc Stock (BBOT) Year by Year Forecast

$36.36
price down icon 0.93%
$83.10
price down icon 3.56%
$27.82
price down icon 2.76%
$96.74
price down icon 7.26%
$145.93
price up icon 0.10%
biotechnology ONC
$324.34
price down icon 3.38%
Cap:     |  Volume (24h):